Investor Presentations Sydney and Melbourne
Investor Presentations Sydney and Melbourne
Sydney, Feb 11, 2019 AEST (ABN Newswire) - This month, Anatara's CEO, Steve Lydeamore will be presenting to investors at events in Sydney and Melbourne. We would like to extend to you the invitation to attend.

Details and registration links are summarised below:

Melbourne Proactive Investors CEO Session

- 19th February from 12noon to 2pm

- CQ Melbourne, Events Room 1 (113 Queen Street, Melbourne)

Register here (free) by 15th February to attend:
http://www.abnnewswire.net/lnk/867T06P6

Sydney Wholesale Investor Emergence 2019 Conference

- 28th February from 9am to 6pm

InterContinental Sydney, L2 (117 Macquarie Street, Sydney)

Register by 26th February to attend*.

* Please note that while the Wholesale Investor Emergence conference requires payment, Anatara has 10 free tickets available to give away to our investors. To request your ticket (allocated on a first come, first served basis), please contact Hayley van der Meer at hvandermeer@anatara.com.


About Anatara Lifesciences Ltd

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Following the successful licencing of our first product to leading global animal health company, Zoetis Inc, we are now focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

    


Contact

General inquiries
Steven Lydeamore
CEO
Anatara Lifesciences
T: +61-438-027-172
E: slydeamore@anatara.com

Media inquiries:
Jane Lowe
Managing Director
IR Department
T: +61-411-117-774
E: jane.lowe@irdepartment.com.au


Related Companies

Anatara Lifesciences Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 708) (Last 30 Days: 1028) 
ANALYTICS: LOGIN HERE

Anatara Lifesciences Ltd NEWS: RECENT VISITS (13099)

Research Report

Social Media